PL2001876T3 - Związki 8-azabicyklo/3.2.1/oktanu jako antagoniści receptora opioidowego mu - Google Patents

Związki 8-azabicyklo/3.2.1/oktanu jako antagoniści receptora opioidowego mu

Info

Publication number: PL2001876T3
Authority: PL; Poland
Prior art keywords: receptor antagonists; opioid receptor; octane compounds; octane; compounds
Prior art date: 2006-03-01

Application number

PL07752111T

Other languages

English (en)

Inventor

Daniel Long

Timothy J Church

John R Jacobsen

Lan Jiang

Daisuke Roland Saito

Ioanna Stergiades

Dyke Priscilla Van

Original Assignee

Theravance Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-01

Filing date

2007-02-28

Publication date

2011-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38436795&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2001876(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-02-28 Application filed by Theravance Inc filed Critical Theravance Inc

2011-10-31 Publication of PL2001876T3 publication Critical patent/PL2001876T3/pl

Links

229940123257 Opioid receptor antagonist Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
102000051367 mu Opioid Receptors Human genes 0.000 title 1
108020001612 μ-opioid receptors Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL07752111T 2006-03-01 2007-02-28 Związki 8-azabicyklo/3.2.1/oktanu jako antagoniści receptora opioidowego mu PL2001876T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US77796206P	2006-03-01	2006-03-01
US84102806P	2006-08-30	2006-08-30
EP07752111A EP2001876B1 (en)	2006-03-01	2007-02-28	8-azabicycloý3.2.1¨octane compounds as mu opioid receptor antagonists
PCT/US2007/005388 WO2007103187A2 (en)	2006-03-01	2007-02-28	8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Publications (1)

Publication Number	Publication Date
PL2001876T3 true PL2001876T3 (pl)	2011-10-31

Family

ID=38436795

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07752111T PL2001876T3 (pl)	2006-03-01	2007-02-28	Związki 8-azabicyklo/3.2.1/oktanu jako antagoniści receptora opioidowego mu

Country Status (24)

Country	Link
US (11)	US7622508B2 (pl)
EP (1)	EP2001876B1 (pl)
JP (2)	JP5086280B2 (pl)
KR (1)	KR101376479B1 (pl)
AR (1)	AR059690A1 (pl)
AT (1)	ATE509928T1 (pl)
AU (1)	AU2007224213B2 (pl)
BR (1)	BRPI0708490B8 (pl)
CA (1)	CA2646409C (pl)
CY (1)	CY1111747T1 (pl)
DK (1)	DK2001876T3 (pl)
HR (1)	HRP20110590T1 (pl)
IL (1)	IL193690A (pl)
MA (1)	MA30284B1 (pl)
MX (1)	MX2008011165A (pl)
MY (1)	MY145633A (pl)
NZ (1)	NZ570764A (pl)
PE (1)	PE20071311A1 (pl)
PL (1)	PL2001876T3 (pl)
PT (1)	PT2001876E (pl)
RU (1)	RU2423362C2 (pl)
SI (1)	SI2001876T1 (pl)
TW (1)	TWI379832B (pl)
WO (1)	WO2007103187A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY145633A (en) *	2006-03-01	2012-03-15	Theravance Inc	8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI409067B (zh)	2007-02-28	2013-09-21	Theravance Inc	８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型
TWI415850B (zh) *	2007-07-20	2013-11-21	Theravance Inc	製備ｍｕ類鴉片受體拮抗劑之中間物的方法
WO2009029257A1 (en) *	2007-08-27	2009-03-05	Theravance, Inc.	Disubstituted alkyl-8-azabicyclo [3.2.1.] octane compounds as mu opioid receptor antagonists
US7902221B2 (en) *	2007-08-27	2011-03-08	Theravance, Inc.	Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
TWI423801B (zh)	2007-08-27	2014-01-21	Theravance Inc	作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物
WO2009029253A1 (en) *	2007-08-27	2009-03-05	Theravance, Inc.	Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
BR112012006069A8 (pt) *	2009-09-18	2017-10-10	Adolor Corp	Método para tratar ou prevenir constipação induzida e disfunção intestinal induzida por opióide em um humano, e, uso de uma quantidade terapeuticamente efetiva de composto
US20120122928A1 (en)	2010-08-11	2012-05-17	Bayer Cropscience Ag	Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
EP2423210A1 (de)	2010-08-25	2012-02-29	Bayer CropScience AG	Heteroarylpiperidin- und -piperazinderivate als Fungizide
US8759527B2 (en)	2010-08-25	2014-06-24	Bayer Cropscience Ag	Heteroarylpiperidine and -piperazine derivatives as fungicides
BR112013010497B1 (pt)	2010-10-27	2018-07-17	Bayer Intellectual Property Gmbh	derivados de heteroaril - piperidina e - piperazina enquanto fungicidas, composição os compreendendo, bem como processo para a produção de composições para controle de fungos fitopatogênicos nocivos e método para controle de fungos fitopatogênicos nocivos
JP5703009B2 (ja) *	2010-12-16	2015-04-15	住友精化株式会社	スルホン化合物、スルホン化合物の製造方法、および電気化学デバイス用電解液
BR112013019667B1 (pt)	2011-02-01	2019-07-02	Bayer Intellectual Property Gmbh	Compostos derivados de heteroaril-piperidina e -piperazina, seus usos, composição, processos de produção de compostos e de composições, método para o controle de fungos fitopatogênicos prejudiciais
ES2661849T3 (es)	2011-09-15	2018-04-04	Bayer Intellectual Property Gmbh	Piperidinpirazoles como fungicidas
ES2647442T3 (es)	2011-12-27	2017-12-21	Bayer Intellectual Property Gmbh	Compuestos intermedios para la preparación de derivados de heteroarilpiperidina y de heteroarilpiperazina como fungicidas
EP3082816B1 (en)	2013-12-20	2019-03-20	Indivior UK Limited	Intranasal naloxone compositions and methods of making and using same
WO2016161069A1 (en)	2015-04-02	2016-10-06	Theravance Biopharma R&D Ip, Llc	Combination dosage form of a mu opioid receptor antagonist and an opioid agent
JP2021512952A (ja)	2018-02-05	2021-05-20	アルカームス・インコーポレイテッド	疼痛の処置のための化合物
US20230416243A1 (en) *	2020-11-06	2023-12-28	Actinogen Medical Limited	Process for Preparing Heterocyclic Methanone Compounds and AZA-Bicyclo Intermediates Thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1067824B (de) *	1954-10-20	1959-10-29	Sandoz Ag	Verfahren zur Herstellung saeureamidartiger Tropanabkoemmlinge
US5159081A (en)	1991-03-29	1992-10-27	Eli Lilly And Company	Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
UA58476C2 (uk) *	1997-10-09	2003-08-15	Санофі-Сентелябо	Похідні 8-азабіцикло[3.2.1]октан-3-метанаміну, фармацевтична композиція та лікарський засіб
US6900228B1 (en)	1998-03-10	2005-05-31	Research Triangle Institute	Opiate compounds, methods of making and methods of use
GB9810671D0 (en)	1998-05-18	1998-07-15	Pfizer Ltd	Anti-pruritic agents
TWI244481B (en)	1998-12-23	2005-12-01	Pfizer	3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB9912410D0 (en)	1999-05-28	1999-07-28	Pfizer Ltd	Compounds useful in therapy
US6469030B2 (en)	1999-11-29	2002-10-22	Adolor Corporation	Methods for the treatment and prevention of ileus
IL151550A0 (en)	2000-03-03	2003-04-10	Ortho Mcneil Pharm Inc	3-(diarylmethylene)-8-azabicyclo [3.2.1] octane derivatives
US20030181447A1 (en) *	2001-02-22	2003-09-25	Boyd Robert E.	3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
US20020025948A1 (en)	2000-06-23	2002-02-28	Banks Bernard Joseph	3-azabicyclo[3.1.0]hexane derivatives useful in therapy
PT1443046E (pt)	2001-10-09	2009-02-26	Nisshin Pharma Inc	Novas 4-(2-furoil)aminopiperidinas, produtos intermédios para a sua síntese, processos para a sua produção e utilização das mesmas em medicina
PL368919A1 (pl)	2001-10-22	2005-04-04	Pfizer Products Inc.	Pochodne 3-azabicyklo[3.1.0]heksanu jako antagoniści receptorów opioidowych
US7381721B2 (en)	2003-03-17	2008-06-03	Adolor Corporation	Substituted piperidine compounds
US20040204453A1 (en)	2003-04-14	2004-10-14	Pfizer Inc	4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
US7056930B2 (en) *	2003-04-14	2006-06-06	Pfizer Inc.	2-Azabicyclo[3.3.1]nonane derivatives
MXPA05011070A (es)	2003-04-14	2005-12-12	Pfizer Prod Inc	Derivados de 3-azabiciclo [3.2.1] octano.
MXPA05011163A (es)	2003-04-15	2005-12-14	Pfizer Prod Inc	Derivados de 3-benzhidriliden-8-azabiciclo[3.2.1]octano con actividad de receptores opioides.
US6992090B2 (en)	2003-06-16	2006-01-31	Adolor Corporation	Substituted piperidine compounds and methods of their use
US7435822B2 (en)	2004-02-03	2008-10-14	Janssen Pharmaceutica N.V.	3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
US7087749B2 (en)	2004-03-11	2006-08-08	Adolor Corporation	Substituted piperidine compounds and methods of their use
US7538110B2 (en)	2005-10-27	2009-05-26	Adolor Corporation	Opioid antagonists
MY145633A (en) *	2006-03-01	2012-03-15	Theravance Inc	8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
JP2010509227A (ja)	2006-11-07	2010-03-25	ネクターセラピューティックスエイエル，コーポレイション	オピオイド作動薬およびオピオイド拮抗薬の用量形態および同時投与
TWI409067B (zh) *	2007-02-28	2013-09-21	Theravance Inc	８-氮雜雙環〔３．２．１〕辛烷化合物之結晶型
TWI415850B (zh)	2007-07-20	2013-11-21	Theravance Inc	製備ｍｕ類鴉片受體拮抗劑之中間物的方法
WO2009029257A1 (en)	2007-08-27	2009-03-05	Theravance, Inc.	Disubstituted alkyl-8-azabicyclo [3.2.1.] octane compounds as mu opioid receptor antagonists
TWI423801B (zh)	2007-08-27	2014-01-21	Theravance Inc	作為μ類鴉片受體拮抗劑之８－氮雜雙環〔３．２．１〕辛基－２－羥基苯甲醯胺化合物
WO2009029253A1 (en)	2007-08-27	2009-03-05	Theravance, Inc.	Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
US7902221B2 (en) *	2007-08-27	2011-03-08	Theravance, Inc.	Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

2007
- 2007-02-07 MY MYPI20070176A patent/MY145633A/en unknown
- 2007-02-26 TW TW096106339A patent/TWI379832B/zh active
- 2007-02-28 PL PL07752111T patent/PL2001876T3/pl unknown
- 2007-02-28 CA CA2646409A patent/CA2646409C/en active Active
- 2007-02-28 SI SI200730691T patent/SI2001876T1/sl unknown
- 2007-02-28 KR KR1020087024027A patent/KR101376479B1/ko active Active
- 2007-02-28 JP JP2008557405A patent/JP5086280B2/ja active Active
- 2007-02-28 RU RU2008138875/04A patent/RU2423362C2/ru active
- 2007-02-28 PE PE2007000212A patent/PE20071311A1/es active IP Right Grant
- 2007-02-28 AU AU2007224213A patent/AU2007224213B2/en active Active
- 2007-02-28 NZ NZ570764A patent/NZ570764A/en not_active IP Right Cessation
- 2007-02-28 EP EP07752111A patent/EP2001876B1/en active Active
- 2007-02-28 DK DK07752111.0T patent/DK2001876T3/da active
- 2007-02-28 MX MX2008011165A patent/MX2008011165A/es active IP Right Grant
- 2007-02-28 WO PCT/US2007/005388 patent/WO2007103187A2/en not_active Ceased
- 2007-02-28 BR BRPI0708490A patent/BRPI0708490B8/pt not_active IP Right Cessation
- 2007-02-28 US US11/711,961 patent/US7622508B2/en active Active
- 2007-02-28 AR ARP070100835A patent/AR059690A1/es active IP Right Grant
- 2007-02-28 HR HR20110590T patent/HRP20110590T1/hr unknown
- 2007-02-28 AT AT07752111T patent/ATE509928T1/de active
- 2007-02-28 PT PT07752111T patent/PT2001876E/pt unknown
2008
- 2008-08-26 IL IL193690A patent/IL193690A/en active IP Right Grant
- 2008-09-17 MA MA31246A patent/MA30284B1/fr unknown
2009
- 2009-10-14 US US12/578,715 patent/US8263618B2/en active Active
2011
- 2011-08-09 CY CY20111100762T patent/CY1111747T1/el unknown
2012
- 2012-06-20 US US13/527,942 patent/US8664242B2/en active Active
- 2012-08-01 JP JP2012171119A patent/JP2012211193A/ja not_active Withdrawn
2014
- 2014-01-15 US US14/156,014 patent/US8927573B2/en active Active
- 2014-11-06 US US14/534,798 patent/US9206172B2/en active Active
2015
- 2015-10-29 US US14/926,225 patent/US9663509B2/en active Active
2017
- 2017-04-25 US US15/496,269 patent/US10081626B2/en active Active
2018
- 2018-08-16 US US15/998,823 patent/US10377751B2/en active Active
2019
- 2019-06-24 US US16/449,857 patent/US10745394B2/en active Active
2020
- 2020-07-07 US US16/922,414 patent/US11548887B2/en active Active
2022
- 2022-12-09 US US18/078,891 patent/US20230183232A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW200800981A (en)	2008-01-01
US8664242B2 (en)	2014-03-04
SI2001876T1 (sl)	2011-09-30
HK1125935A1 (en)	2009-08-21
MA30284B1 (fr)	2009-03-02
BRPI0708490B8 (pt)	2021-05-25
US7622508B2 (en)	2009-11-24
US20160176863A1 (en)	2016-06-23
WO2007103187A2 (en)	2007-09-13
US9206172B2 (en)	2015-12-08
US20140288112A1 (en)	2014-09-25
DK2001876T3 (da)	2011-08-29
EP2001876A2 (en)	2008-12-17
EP2001876B1 (en)	2011-05-18
US20170349578A1 (en)	2017-12-07
AU2007224213B2 (en)	2012-06-14
US10745394B2 (en)	2020-08-18
US10377751B2 (en)	2019-08-13
RU2423362C2 (ru)	2011-07-10
BRPI0708490A2 (pt)	2011-05-31
RU2008138875A (ru)	2010-04-10
KR20080100282A (ko)	2008-11-14
PT2001876E (pt)	2011-08-18
BRPI0708490B1 (pt)	2019-07-30
JP2012211193A (ja)	2012-11-01
MX2008011165A (es)	2008-09-15
US20150291579A1 (en)	2015-10-15
US20100035921A1 (en)	2010-02-11
US20190119267A1 (en)	2019-04-25
US10081626B2 (en)	2018-09-25
CA2646409A1 (en)	2007-09-13
NZ570764A (en)	2011-08-26
US9663509B2 (en)	2017-05-30
PE20071311A1 (es)	2007-12-29
US8263618B2 (en)	2012-09-11
US20190308966A1 (en)	2019-10-10
US20130158060A1 (en)	2013-06-20
AR059690A1 (es)	2008-04-23
HRP20110590T1 (hr)	2011-09-30
CA2646409C (en)	2015-11-10
IL193690A (en)	2013-02-28
JP5086280B2 (ja)	2012-11-28
US20070219278A1 (en)	2007-09-20
TWI379832B (en)	2012-12-21
IL193690A0 (en)	2009-08-03
KR101376479B1 (ko)	2014-03-27
CY1111747T1 (el)	2015-10-07
JP2009528371A (ja)	2009-08-06
US11548887B2 (en)	2023-01-10
MY145633A (en)	2012-03-15
ATE509928T1 (de)	2011-06-15
US20210024515A1 (en)	2021-01-28
AU2007224213A1 (en)	2007-09-13
US20230183232A1 (en)	2023-06-15
US8927573B2 (en)	2015-01-06
WO2007103187A3 (en)	2007-11-01

Publication	Publication Date	Title
PT2001876E (pt)	2011-08-18	Compostos de 8-azabiciclo[3.2.1]octano como antagonistas do receptor opióide mu
EP2099454A4 (en)	2010-11-10	AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS
SI2094690T1 (sl)	2011-07-29	Derivati 2-aza-biciklo(3.1.0)heksana kot antagonisti receptorja za oreksin
IL239402A0 (en)	2015-07-30	Kinase antagonists
IL198825A0 (en)	2010-02-17	Substituted diazepan compounds as orexin receptor antagonists
ZA200800320B (en)	2009-02-25	Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists
ZA201001597B (en)	2012-09-29	Octahydropentalene compounds as chemokine receptor antagonists
IL198241A0 (en)	2009-12-24	Pyrazoline compounds as mineralocorticoid receptor antagonists
IL194734A0 (en)	2009-08-03	Pharmaceutical compositions containing opioid antagonists
EP2054434A4 (en)	2011-07-13	ANTAGONISTS AGAINST MYOSTATIN
IL196587A0 (en)	2009-11-18	2-phenyl-indoles as prostaglandin d2 receptor antagonists
BRPI0815797A2 (pt)	2015-06-16	Compostos 8-azabiciclo[3.2.1]octil-2-hidroxibanzamida como antagonistas de receptor opióide mu
ZA200903334B (en)	2010-04-28	Substituted diazepan compounds as orexin receptor antagonists
EP1758458A4 (en)	2009-12-09	COMPOSITIONS CONTAINING OPIOIDANT AGONISTS
IL195807A0 (en)	2009-09-01	Cgrp receptor antagonists
IL198542A0 (en)	2010-02-17	2-aminoquinolines as 5-ht(5a)receptor antagonists
ZA200903499B (en)	2010-03-31	Indoles which act as via receptor antagonists
AP2010005512A0 (en)	2010-12-31	Novel compounds active as muscarinic receptor antagonists.
IL195027A0 (en)	2009-08-03	Constrained compounds as cgrp-receptor antagonists
ZA200802339B (en)	2009-10-28	Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
IL179888A0 (en)	2007-05-15	Compounds as ccr5 antagonists
ZA200809205B (en)	2010-01-27	Constrained compounds as CGRP-receptor antagonists
ZA200903496B (en)	2010-03-31	Spiro-piperidine derivatives as via receptor antagonists
GB201000798D0 (en)	2010-03-03	Poly-TLR antagonists
ZA200810564B (en)	2009-11-25	2-phenyl-indoles as prostaglandin D2 receptor antagonists